Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 16, 2015, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $101.50 to $30,000,001.88.

Highlighted Stocks Traded by Insiders:

Regional Management (RM) - FREE Research Report

Freiberg Steven J, who is Director at Regional Management, bought 14,589 shares at $15.27 on March 16, 2015. Following this transaction, the Director owned 20,465 shares meaning that the stake was boosted by 248.28% with the 14,589-share transaction.

Taggart Daniel J., who is SVP and Chief Risk Officer at Regional Management, bought 6,551 shares at $15.42 on March 16, 2015. Following this transaction, the SVP and Chief Risk Officer owned 6,551 shares meaning that the stake was boosted by 100% with the 6,551-share transaction.

The shares most recently traded at $15.34, down $0.08, or 0.52% since the insider transaction. Historical insider transactions for Regional Management go as follows:

  • 4-Week # shares bought: 75,000
  • 4-Week # shares sold: 9,389
  • 12-Week # shares bought: 75,000
  • 12-Week # shares sold: 9,389
  • 24-Week # shares bought: 87,000
  • 24-Week # shares sold: 9,389

The average volume for Regional Management has been 129,800 shares per day over the past 30 days. Regional Management has a market cap of $198.2 million and is part of the financial sector and financial services industry. Shares are down 3.54% year-to-date as of the close of trading on Monday.

Regional Management Corp., a diversified specialty consumer finance company, provides various loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other traditional lenders. The company has a P/E ratio of 12.8. Currently, there are no analysts who rate Regional Management a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RM - FREE

TheStreet Quant Ratings rates Regional Management as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Regional Management Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BioMed Realty (BMR) - FREE Research Report

Wilson Margaret Faye, who is Director at BioMed Realty, bought 2,300 shares at $21.76 on March 16, 2015. Following this transaction, the Director owned 33,946 shares meaning that the stake was boosted by 7.27% with the 2,300-share transaction.

Willey Stephen A., who is VP, Chief Accounting Officer at BioMed Realty, sold 1,974 shares at $22.07 on March 16, 2015. Following this transaction, the VP, Chief Accounting Officer owned 24,224 shares meaning that the stake was reduced by 7.53% with the 1,974-share transaction.

The shares most recently traded at $21.99, down $0.08, or 0.36% since the insider transaction. Historical insider transactions for BioMed Realty go as follows:

  • 4-Week # shares sold: 1,388
  • 12-Week # shares sold: 1,388
  • 24-Week # shares sold: 1,388

The average volume for BioMed Realty has been 2.1 million shares per day over the past 30 days. BioMed Realty has a market cap of $4.4 billion and is part of the financial sector and real estate industry. Shares are up 1.11% year-to-date as of the close of trading on Monday.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The stock currently has a dividend yield of 4.82%. The company has a P/E ratio of 22.0. Currently, there are 6 analysts who rate BioMed Realty a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMR - FREE

TheStreet Quant Ratings rates BioMed Realty as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, compelling growth in net income, revenue growth, reasonable valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full BioMed Realty Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Pinnacle Foods (PF) - FREE Research Report

Gamgort Robert James, who is Chief Executive Officer at Pinnacle Foods, sold 100,000 shares at $37.07 on March 16, 2015. Following this transaction, the Chief Executive Officer owned 811,125 shares meaning that the stake was reduced by 10.98% with the 100,000-share transaction.

The shares most recently traded at $39.33, up $2.26, or 5.75% since the insider transaction. Historical insider transactions for Pinnacle Foods go as follows:

  • 4-Week # shares bought: 6,500
  • 4-Week # shares sold: 2,100
  • 12-Week # shares bought: 6,500
  • 12-Week # shares sold: 71,900
  • 24-Week # shares bought: 6,500
  • 24-Week # shares sold: 239,555

The average volume for Pinnacle Foods has been 908,400 shares per day over the past 30 days. Pinnacle Foods has a market cap of $4.5 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 12.52% year-to-date as of the close of trading on Monday.

Pinnacle Foods Inc., through its subsidiaries, manufactures, markets, and distributes branded convenience food products in North America. It operates through three segments: Birds Eye Frozen, Duncan Hines Grocery, and Specialty Foods. The stock currently has a dividend yield of 2.41%. The company has a P/E ratio of 18.3. Currently, there are 5 analysts who rate Pinnacle Foods a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PF - FREE

TheStreet Quant Ratings rates Pinnacle Foods as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, good cash flow from operations and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and poor profit margins. Get the full Pinnacle Foods Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null